An FDA pilot program using technology with which law enforcement and security agencies test for explosives and illegal narcotics found undeclared drug ingredients in 65% of tested products at two international mail facilities that were labeled as dietary supplements.
Commissioner Scott Gottlieb and other agency officials on March 21 announced that the six-month pilot demonstrated the ion mobility spectrometer portable screening device is reliable, efficient, produced valid results and supported adding the devices at two additional IMFs. FDA says it will refine its use of the device and eventually install it in all nine US IMF facilities so its staff can more quickly determine whether products contain undeclared drug ingredients. The device compares the chemical signature of an unknown substance against the signatures of known compounds in a process that takes less than 30 second
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?